LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 80 filers reported holding LYELL IMMUNOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $37 | -51.3% | 25,610 | -25.1% | 0.00% | -50.0% |
| Q1 2024 | $76 | +49.0% | 34,177 | -1.1% | 0.01% | +50.0% |
| Q3 2023 | $51 | -8.9% | 34,540 | +114.7% | 0.00% | -42.9% |
| Q4 2022 | $56 | -100.0% | 16,084 | -65.8% | 0.01% | -78.1% |
| Q1 2022 | $237,000 | -52.1% | 46,990 | +54.1% | 0.03% | -42.9% |
| Q2 2021 | $495,000 | – | 30,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $69,963,292 | 35.72% |
| Orland Properties Ltd | 15,093,969 | $52,376,072 | 27.91% |
| Foresite Capital Management IV, LLC | 10,000,000 | $34,700,000 | 14.82% |
| MIC Capital Management UK LLP | 3,060,569 | $10,620,174 | 2.10% |
| Alphabet Inc. | 5,865,125 | $20,351,984 | 1.18% |
| HSG Holding Ltd | 3,045,997 | $10,569,610 | 1.07% |
| Artal Group S.A. | 700,000 | $2,429 | 0.14% |
| Eagle Health Investments LP | 100,000 | $347,000 | 0.08% |
| Virtus ETF Advisers LLC | 39,345 | $136,527 | 0.07% |
| BBR PARTNERS, LLC | 164,041 | $569,222 | 0.06% |